Results 31 to 40 of about 889,891 (289)

Prevalence and association of post-renal transplant anemia

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2012
In some renal allograft recipients, anemia persists or develops following transplantation. Anemia is associated with pre-operative blood loss and allograft dysfunction, including delayed graft function, acute rejection and chronic allograft dysfunction ...
Hesham Elsayed   +5 more
doaj   +1 more source

Receptor-mediated mitophagy regulates EPO production and protects against renal anemia

open access: yeseLife, 2021
Erythropoietin (EPO) drives erythropoiesis and is secreted mainly by the kidney upon hypoxic or anemic stress. The paucity of EPO production in renal EPO-producing cells (REPs) causes renal anemia, one of the most common complications of chronic ...
Guangfeng Geng   +15 more
doaj   +1 more source

Administration of iron in renal anemia

open access: yesVojnosanitetski pregled, 2015
nema
Mileta Poskurica   +2 more
openaire   +3 more sources

Anaemia management in dialysis patients in Switzerland "AIMS" [PDF]

open access: yes, 2005
The prevalence of chronic kidney disease (CKD) is increasing all over the world. In the US, out of over 400,000 were end-stage renal disease (ESRD) patients in 2002, more than 90,000 were new ESRD patients.
Lötscher, Nathalie G.
core   +1 more source

Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes

open access: yesRenal Failure, 2022
We aimed to determine the utility of biopsy data and anemia for the prediction of renal outcomes in Chinese patients with type 2 diabetes. In total, 441 Chinese patients with type 2 diabetes and biopsy-confirmed diabetic nephropathy (DN) were enrolled in
Lijun Zhao   +16 more
doaj   +1 more source

Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy [PDF]

open access: yes, 1991
Primary as well as secondary hyperparathyroidism may be associated with anemia, and parathyroidectomy (PTx) may improve or even heal it. The precise link between the two conditions is still matter of discussion.
Zins, B.   +8 more
core   +1 more source

The cardio-renal anemia syndrome

open access: yesMedicinski pregled, 2007
Introduction. The problem of anemia in congestive heart failure and chronic kidney disease was thought to be insignificant for a long period of time. Recent investigations pointed out that the problem of anemia should be defined in the context of the cardio-renal anemia syndrome. A positive feedback mechanism indicates that cardio-renal anemia syndrome
Sinisa, Dimković, Nada, Dimkovic
openaire   +3 more sources

Anemia en la enfermedad renal crónica: protocolo de estudio, manejo y derivación a Nefrología

open access: yesNefrología, 2018
El objetivo del protocolo es conocer qué estudios deben solicitarse ante una anemia en un paciente con enfermedad renal crónica, el diagnóstico diferencial de la anemia renal, conocer y corregir otras anemias carenciales y los criterios de remisión del ...
Aleix Cases   +6 more
doaj   +3 more sources

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia

open access: yesKidney Diseases, 2022
Background: Anemia is a common complication of chronic kidney disease. The hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) is a new class of oral drugs for the treatment of renal anemia.
Jing Li, Volker H. Haase, Chuan-Ming Hao
doaj   +1 more source

Home - About - Disclaimer - Privacy